Rafael Durán

4.0k total citations
124 papers, 2.8k citations indexed

About

Rafael Durán is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rafael Durán has authored 124 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hepatology, 34 papers in Pulmonary and Respiratory Medicine and 32 papers in Surgery. Recurrent topics in Rafael Durán's work include Hepatocellular Carcinoma Treatment and Prognosis (63 papers), MRI in cancer diagnosis (18 papers) and Liver Disease and Transplantation (18 papers). Rafael Durán is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (63 papers), MRI in cancer diagnosis (18 papers) and Liver Disease and Transplantation (18 papers). Rafael Durán collaborates with scholars based in Switzerland, United States and France. Rafael Durán's co-authors include Alban Denys, Julius Chapiro, MingDe Lin, Jean-François H. Geschwind, Rüdiger Schernthaner, Pierre Bize, Boris Guiu, Antonia Digklia, Naïk Vietti Violi and Jean‐François Knebel and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Rafael Durán

119 papers receiving 2.8k citations

Peers

Countries citing papers authored by Rafael Durán

Since Specialization

Citations

This map shows the geographic impact of Rafael Durán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Durán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Durán more than expected).

Fields of papers citing papers by Rafael Durán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Durán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Durán. The network helps show where Rafael Durán may publish in the future.

Co-authorship network of co-authors of Rafael Durán

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Durán. A scholar is included among the top collaborators of Rafael Durán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Durán. Rafael Durán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model 2024 ·Clinical Cancer Research ·Chakradhar Yakkala, Jesús Corría-Osorio, Lana E. Kandalaft, Alban Denys, Bhanu Koppolu, Rafael Durán	2
2	Measure of 90Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison 99mTc-MAA SPECT/CT dosimetry 2024 ·PubMed ·Sarah Boughdad, Rafael Durán, John O. Prior, (unknown), (unknown), (unknown), (unknown), Silvano Gnesin, Niklaus Schaefer	1
3	99mTc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy 2023 ·Scientific Reports ·(unknown), Silvano Gnesin, Vincent Dunet, (unknown), Antonia Digklia, Sarah Boughdad, Niklaus Schaefer, John O. Prior, (unknown), Georgia Tsoumakidou, Alban Denys, Rafael Durán	1
4	How to outsmart the cold tumor microenvironment: Design of STING ligand nanoparticles for improved cancer immunotherapy 2023 ·OpenNano ·(unknown), Stoyan Tankov, (unknown), Chakradhar Yakkala, Rafael Durán, Paul R. Walker, Gerrit Borchard, Olivier Jordan	1
5	Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment 2023 ·Radiology Imaging Cancer ·(unknown), Roberto Cannella, (unknown), Louis de Mestier, Marco Dioguardi Burgio, (unknown), Olivia Hentic, Jérôme Cros, Lambros Tsélikas, Philippe Ruszniewski, Marie‐Pierre Vullierme, Valérie Vilgrain, Rafael Durán, Maxime Ronot	3
6	Tumor response assessment on imaging following immunotherapy 2022 ·Frontiers in Oncology ·(unknown), Clarisse Dromain, Naïk Vietti Violi, Sarah Boughdad, Rafael Durán	26
7	Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study 2021 ·World Journal of Surgery ·Kosuke Kobayashi, Émilie Uldry, Takashi Kokudo, Alessandra Cristaudi, Yoshikuni Kawaguchi, Chikara Shirata, (unknown), Olivier Dormond, Rafael Durán, Kiyoshi Hasegawa, Nicolas Demartines, Nermin Halkic	3
8	Induction of Robust Future Liver Remnant Hypertrophy Before Hepatectomy With a Modified Liver Venous Deprivation Technique Using a Trans-venous Access for Hepatic Vein Embolization 2021 ·PubMed ·Nils Degrauwe, Rafael Durán, Emmanuel Melloul, Nermin Halkic, Nicolas Demartines, Alban Denys	3
9	Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper 2019 ·Radiology ·Joseph P. Erinjeri, G Fine, Gosse J. Adema, Muneeb Ahmed, Julius Chapiro, Martijn H. den Brok, Rafael Durán, Stephen J. Hunt, D. Johnson, Jens Ricke, Daniel Y. Sze, Beau Toskich, Bradford J. Wood, David A. Woodrum, S. Nahum Goldberg	53
10	Radiofrequency Ablation of Liver Tumors: No Difference in the Ablation Zone Volume Between Cirrhotic and Healthy Liver 2018 ·CardioVascular and Interventional Radiology ·Christophe Cassinotto, Alban Denys, (unknown), Rafael Durán, Arnaud Hocquelet, Lauranne Piron, Boris Guiu	20
11	[Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy]. 2017 ·PubMed ·(unknown), Rafael Durán, Alban Denys, Antonia Digklia	2
12	Drug-eluting embolic microspheres for local drug delivery – State of the art 2017 ·Journal of Controlled Release ·(unknown), Rafael Durán, Alban Denys, Pierre Bize, Gerrit Borchard, Olivier Jordan	55
13	Which Criteria Applied in Multi-Phasic CT Can Predict Early Tumor Response in Patients with Hepatocellular Carcinoma Treated Using Conventional TACE: RECIST, mRECIST, EASL or qEASL? 2017 ·CardioVascular and Interventional Radiology ·Yan Zhao, Rafael Durán, Wei Bai, Sonia Sahu, Wenjun Wang, Sven Kabus, MingDe Lin, Guohong Han, Jean-François Geschwind	24
14	Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer 2016 ·Clinical Cancer Research ·Rafael Durán, Sahar Mirpour, (unknown), Shanmugasundaram Ganapathy‐Kanniappan, Cory Brayton, Toby C. Cornish, Boris Gorodetski, Juvenal Reyes, Julius Chapiro, Rüdiger Schernthaner, Constantine Frangakis, MingDe Lin, Jessica D. Sun, Charles P. Hart, Jean-François Geschwind	25
15	Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival? 2016 ·Radiology ·Sonia Sahu, Ruediger E. Schernthaner, Roberto Ardon, Julius Chapiro, Yan Zhao, Jae Ho Sohn, Florian Nima Fleckenstein, MingDe Lin, Jean-François Geschwind, Rafael Durán	43
16	3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival 2016 ·European Radiology ·Florian Nima Fleckenstein, Rüdiger Schernthaner, Rafael Durán, Jae Ho Sohn, Sonia Sahu, Yan Zhao, Bernd Hamm, Bernhard Gebauer, MingDe Lin, Jean-François H. Geschwind, Julius Chapiro	25
17	Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis 2016 ·Translational Oncology ·Florian Nima Fleckenstein, Rüdiger Schernthaner, Rafael Durán, Jae Ho Sohn, Sonia Sahu, Karen Marshall, MingDe Lin, Bernhard Gebauer, Julius Chapiro, Riad Salem, Jean-François H. Geschwind	9
18	Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer 2014 ·Clinical Cancer Research ·Julius Chapiro, Surojit Sur, Lynn Jeanette Savic, Shanmugasundaram Ganapathy‐Kanniappan, Juvenal Reyes, Rafael Durán, Sivarajan T. Chettiar, (unknown), MingDe Lin, Weibo Luo, Phuoc T. Tran, Joseph M. Herman, Gregg L. Semenza, Andrew J. Ewald, Bert Vogelstein, Jean-François H. Geschwind	48
19	Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization 2014 ·CardioVascular and Interventional Radiology ·Ruediger E. Schernthaner, MingDe Lin, Rafael Durán, Julius Chapiro, Zhijun Wang, Jean-François H. Geschwind	22
20	Mioepitelioma en glándulas salivares 2001 ·Acta Otorrinolaringológica Española ·(unknown), (unknown), (unknown), (unknown), Rafael Durán, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact